Provided by Tiger Trade Technology Pte. Ltd.

California Resources

62.12
-0.7100-1.13%
Pre-market: 59.69-2.0250-3.28%08:03 EDT
Volume:1.93M
Turnover:121.76M
Market Cap:5.50B
PE:14.97
High:64.74
Open:63.11
Low:61.93
Close:62.83
52wk High:66.35
52wk Low:30.97
Shares:88.60M
Float Shares:88.50M
Volume Ratio:1.61
T/O Rate:2.18%
Dividend:1.57
Dividend Rate:2.52%
EPS(TTM):4.15
EPS(LYR):4.15
ROE:10.07%
ROA:6.42%
PB:1.50
PE(LYR):14.97

Loading ...

Ovintiv Appoints Gregory P. Hill to Board of Directors

Reuters
·
Jan 30

Revolution Medicines Doses First Patient in Clinical Trial Evaluating RMC-5127, a RAS(ON) G12V-Selective Inhibitor

GlobeNewswire
·
Jan 29

California Resources Is Maintained at Buy by UBS

Dow Jones
·
Jan 27

UBS Adjusts Price Target on California Resources to $63 From $64, Maintains Buy Rating

MT Newswires Live
·
Jan 26

California Resources price target lowered to $63 from $64 at UBS

TIPRANKS
·
Jan 26

Expanding Nadunolimab’s Oncology Footprint: Low-Cost MSS-CRC Study De-Risks Pivotal Pancreatic Program and Supports Buy Rating on Cantargia AB

TIPRANKS
·
Jan 24

Press Release: Adagene Provides Business Update and 2026 Objectives

Dow Jones
·
Jan 23

Analysts Offer Insights on Energy Companies: California Resources Corp (CRC) and Paladin Energy Ltd (OtherPALAF)

TIPRANKS
·
Jan 22

California Resources Is Maintained at Overweight by Barclays

Dow Jones
·
Jan 22

Wells Fargo Sticks to Its Buy Rating for California Resources Corp (CRC)

TIPRANKS
·
Jan 21

U.S. RESEARCH ROUNDUP-Alphabet, Micron Technology, Microsoft

Reuters
·
Jan 20

Analysts Offer Insights on Energy Companies: Gulfport Energy (GPOR) and California Resources Corp (CRC)

TIPRANKS
·
Jan 16

California Resources Corp (CRC) Receives a Buy from J.P. Morgan

TIPRANKS
·
Jan 16

RBC Capital Sticks to Its Buy Rating for California Resources Corp (CRC)

TIPRANKS
·
Jan 16

California Resources Corporation to Announce Fourth Quarter and Full Year Earnings

Reuters
·
Jan 15

Enhanced Genetype colorectal cancer risk test released - supports earlier disease detection and ColoSTAT® targeting

prnewswire
·
Jan 14

Press Release: Exelixis Announces Preliminary Fiscal Year 2025 Financial Results, Provides 2026 Financial Guidance and Outlines Key Priorities and Milestones for 2026

Dow Jones
·
Jan 12

ALX Oncology Advances Separate Clinical Trials Evaluating Investigational CD47-Inhibitor Evorpacept and Novel EGFR-Targeted Antibody-Drug Conjugate ALX2004

GlobeNewswire
·
Jan 08

California Resources Corporation and Los Angeles Rams Score in Carbon Management Initiative

GlobeNewswire
·
Jan 08

BBOT Announces New Clinical Data Advancing Its Portfolio of Three Innovative and Differentiated RAS and PI3Kα Pipeline Programs

GlobeNewswire
·
Jan 07